AsiaMedic Past Earnings Performance

Past criteria checks 1/6

AsiaMedic has been growing earnings at an average annual rate of 64.8%, while the Healthcare industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 7.2% per year. AsiaMedic's return on equity is 9%, and it has net margins of 4.5%.

Key information

64.8%

Earnings growth rate

74.8%

EPS growth rate

Healthcare Industry Growth9.7%
Revenue growth rate7.2%
Return on equity9.0%
Net Margin4.5%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How AsiaMedic makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

Catalist:505 Revenue, expenses and earnings (SGD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2426100
31 Mar 2425200
31 Dec 2324200
30 Sep 2323200
30 Jun 2321300
31 Mar 2320200
31 Dec 2219200
30 Sep 2218100
30 Jun 2218000
31 Mar 2218000
31 Dec 2118100
30 Sep 2118000
30 Jun 2118-200
31 Mar 2117-300
31 Dec 2015-400
30 Sep 2016-300
30 Jun 2016-200
31 Mar 2018-100
31 Dec 1919-100
30 Sep 1919-310
30 Jun 1919-510
31 Mar 1919-520
31 Dec 1819-520
30 Sep 1819-420
30 Jun 1818-420
31 Mar 1819-420
31 Dec 1719-420
30 Sep 1719-320
30 Jun 1720-220
31 Mar 1720-220
31 Dec 1621-220
30 Sep 1621-230
30 Jun 1622-240
31 Mar 1621-240
31 Dec 1521-230
30 Sep 1521030
30 Jun 1521120
31 Mar 1521120
31 Dec 1420120
30 Sep 1418020
30 Jun 1417020
31 Mar 1416010

Quality Earnings: 505 has a high level of non-cash earnings.

Growing Profit Margin: 505's current net profit margins (4.5%) are lower than last year (12.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 505 has become profitable over the past 5 years, growing earnings by 64.8% per year.

Accelerating Growth: 505's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 505 had negative earnings growth (-54.9%) over the past year, making it difficult to compare to the Healthcare industry average (-26%).


Return on Equity

High ROE: 505's Return on Equity (9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/02 06:20
End of Day Share Price 2025/01/23 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AsiaMedic Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution